Kexing Biopharm News

Kexon Pharmaceuticals: Announcement of Resolutions of the 2024 Third Extraordinary General Meeting of Shareholders

Oct 29 00:00

Kexing Pharmaceuticals: Legal Opinion of Beijing Jiayuan Law Firm on the 2024 Third Extraordinary General Meeting of Shareholders of Kexing Biopharmaceutical Co., Ltd.

Oct 29 00:00

Legal Opinion of Beijing Jiayuan Law Firm on the 2024 Third Extraordinary General Meeting of Shareholders of Kexing Biopharmaceutical Co., Ltd.

Oct 29 00:00

Announcement of Resolutions of the 2024 Third Extraordinary General Meeting of Shareholders

Oct 29 00:00

2024 3rd Extraordinary General Meeting of Shareholders Meeting Materials

Oct 19 00:00

Voluntary disclosure of the announcement that paclitaxel for injectable use (albumin binding type) has obtained marketing approval in the UK

Oct 18 00:00

Notice on convening the 3rd Extraordinary General Meeting of Shareholders in 2024

Oct 12 00:00

Voluntary disclosure of the announcement regarding approval for market release of paclitaxel (albumin-bound) for injection by EU Commission.

Jul 29 00:00

Announcement on the Opening of Special Account for Fund-raising and Signing of Tripartite Custody Agreement for Special Account for Fund-raising Storage

Jun 28 00:00

Announcement regarding payment of outstanding taxes.

Jun 22 00:00

Announcement on voluntary disclosure of the completion of the first subject enrollment in the phase I clinical trial for GB08 injection.

Jun 18 00:00

Announcement of resolution of the Second Extraordinary Shareholders' Meeting in 2024.

Jun 15 00:00

Legal opinion from JiaYuan Law Firm, Peking regarding the second interim shareholder meeting in 2024 of Sinovac Biotech Co., Ltd.

Jun 15 00:00

2024 Second Interim Shareholder Meeting Documentation

Jun 7 00:00

Proposal from the second board of directors' audit committee to initiate the selection of audit agencies for the year 2024.

Jun 7 00:00

Announcement regarding the opening of a dedicated settlement account for wealth management products.

Jun 7 00:00

Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders

May 25 00:00

Legal Opinion of Beijing Jiayuan Law Firm on the 2023 Annual General Meeting of Shareholders of Kexing Biopharmaceutical Co., Ltd.

May 25 00:00

Notice on Convening the Second Extraordinary General Meeting of Shareholders in 2024

May 25 00:00

2023 Annual General Meeting of Shareholders Meeting Materials

May 14 00:00